A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects with Cirrhosis and Episodic Hepatic Encephalopathy (HALT-HE)
|Effective start/end date||7/20/09 → 10/26/11|
- Hyperion Therapeutics
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.